Search
for
Sort by
Research 721–750 of 1000+
- Sources of variation in hair cortisol in wild and captive non-human primates
- Acquired scalp alopecia. Part I: A review
- Reflections on how wound healing-promoting effects of the hair follicle can be translated into clinical practice
- The Histopathology of Noncicatricial Alopecia
- REPORTED EXPERIENCES OF PERSONS WITH ALOPECIA AREATA
- Alopecia secondary to anti-tumor necrosis factor-alpha therapy
- ‘Black dots’ seen under trichoscopy are not specific for alopecia areata
- Diagnosis and Management of Primary Cicatricial Alopecia: Part I
- Polycystic Ovary Syndrome and Its Differential Diagnosis
- Hair eruption initiates and commensal skin microbiota aggravate adverse events of anti-EGFR therapy
- Metabolic Syndrome and Skin Diseases
- Insight into Reepithelialization: How Do Mesenchymal Stem Cells Perform?
- Hair through the female life cycle
- Reflectance Confocal Microscopy of the Yellow Dot Pattern in Alopecia Areata
- Use of Leukocyte Platelet (L-PRF) Rich Fibrin in Diabetic Foot Ulcer with Osteomyelitis (Three Clinical Cases Report)
- Hair Cortisol as a Biomarker of Stress Among a First Nation in Canada
- Ectodermal Dysplasia: Otolaryngologic Manifestations and Management
- Hair problems in women
- Polycystic ovary syndrome and its management: In view of oxidative stress
- Zinc in skin pathology and care
- The red face: Rosacea
- Divergent neuroactive steroid responses to stress and ethanol in rat and mouse strains: relevance for human studies
- Straight hair associated with interferon-alfa plus ribavirin in hepatitis C infection
- Cutaneous lupus erythematosus: clinico-pathologic correlation
- Cellular senescence in tissue repair: every cloud has a silver lining
- Severe Physical Complications among Survivors of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis
- Hair dyeing, hair washing and hair cortisol concentrations among women from the healthy start study
- Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata
- Scarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib
- Telogen Effluvium